You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 15, 2025

Drugs Containing Excipient (Inactive Ingredient) BUTYL ALCOHOL


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing BUTYL ALCOHOL excipient, and estimated key patent expiration / generic entry dates

CompanyTradenameIngredientNDCExcipientPotential Generic Entry
Merck Sharp & Dohme Corp REBETOL ribavirin 0085-1351 BUTYL ALCOHOL
Eli Lilly and Company RETEVMO selpercatinib 0002-3977 BUTYL ALCOHOL 2038-10-10
ER Squibb & Sons LLC REYATAZ atazanavir 0003-3624 BUTYL ALCOHOL
Merck Sharp & Dohme LLC TEMODAR temozolomide 0085-3004 BUTYL ALCOHOL
>Company>Tradename>Ingredient>NDC>Excipient>Potential Generic Entry
Showing 1 to 4 of 4 entries

Generic drugs containing BUTYL ALCOHOL excipient

Butyl Alcohol in the Pharmaceutical Industry: Market Dynamics and Financial Trajectory

Introduction

Butyl alcohol, particularly its isomers such as n-butanol and isobutanol, plays a crucial role in the pharmaceutical industry as a solvent, intermediate, and excipient. This article delves into the market dynamics and financial trajectory of butyl alcohol within the pharmaceutical sector.

Market Size and Growth

The global butyl alcohol market, which includes its applications in pharmaceuticals, is anticipated to experience significant growth. By 2036, the butyl alcohol market is projected to reach USD 20 billion, growing at a CAGR of 8% from 2024 to 2036, with the industry size already exceeding USD 10 billion in 2023[3].

Key Applications in Pharmaceuticals

Butyl alcohol is used extensively in the pharmaceutical industry for several critical applications:

Solvent Properties

Butyl alcohol is utilized as a solvent in the formulation of various pharmaceutical products. Its solubility and compatibility with different resins make it an essential component in the synthesis of active pharmaceutical ingredients (APIs) and other pharmaceutical intermediates[1][4].

Intermediate in API Synthesis

In the pharmaceutical sector, butyl alcohol serves as an intermediate in the synthesis of APIs. It is involved in the production of various pharmaceutical compounds, including those used in the treatment of chronic health conditions such as cardiovascular diseases and diabetes[3].

Solvent in Formulations

Butyl alcohol's solvent properties are also leveraged in the formulation of pharmaceutical products. It is used to dissolve and stabilize ingredients, ensuring the efficacy and stability of the final product[4].

Market Drivers

Several factors drive the demand for butyl alcohol in the pharmaceutical industry:

Increasing Demand for Pharmaceuticals

The growing global population and the increasing incidence of chronic illnesses contribute to a sustained demand for pharmaceutical products. This, in turn, drives the demand for butyl alcohol as a critical component in pharmaceutical manufacturing[3].

Expanding Pharmaceutical and Cosmetic Applications

The pharmaceutical and cosmetic industries are expanding rapidly, driven by increasing healthcare needs and consumer demand. Butyl alcohol's role as a solvent and intermediate in these industries ensures a steady and growing demand[1].

Regulatory and Sustainability Factors

Stringent environmental regulations and the push towards green chemistry have made butyl alcohol, considered a relatively eco-friendly solvent, more attractive. This trend aligns with the industry's shift towards sustainable and environmentally responsible practices[3].

Regional Insights

The demand for butyl alcohol varies by region, influenced by local industrial growth and regulatory environments:

Asia Pacific

The Asia Pacific region is poised to dominate the global butyl alcohol market, driven by robust industrial expansion in countries like China and India. The region's growing pharmaceutical and chemical industries are key drivers of this demand[1][3].

North America

In North America, the butyl alcohol market benefits from the abundant availability of petrochemical feedstocks, particularly shale gas. This has led to a significant expansion of the petrochemical industry, providing a stable and cost-effective source of raw materials for butyl alcohol production[3].

Financial Trajectory

The financial trajectory of the butyl alcohol market in the pharmaceutical sector is positive, driven by several factors:

Market Growth Projections

The global butyl alcohol market is expected to grow at a CAGR of 8% from 2024 to 2036, reaching USD 20 billion by the end of the forecast period. This growth is underpinned by the increasing demand from the pharmaceutical and other industries[3].

Revenue Streams

The revenue generated from butyl alcohol sales is substantial and growing. For instance, the n-butanol market alone is projected to reach USD 7.50 billion by 2029, growing at a CAGR of 5.9% from 2024[4].

Cost and Pricing Dynamics

The cost and pricing of butyl alcohol can be volatile due to fluctuations in raw material prices, particularly crude oil. However, companies are mitigating these risks by exploring alternative feedstocks and investing in advanced production technologies to improve efficiency and reduce costs[1].

Challenges and Regulatory Pressures

Despite the positive outlook, the butyl alcohol market faces several challenges:

Regulatory Challenges

The market is subject to regulatory pressures, particularly concerning environmental and health safety. Butyl alcohol and its derivatives must comply with stringent regulations to ensure they do not pose significant environmental or health risks[1].

Raw Material Volatility

The volatility in crude oil prices and geopolitical uncertainties can impact the profitability of butyl alcohol manufacturers. Long-term supply contracts and strategic partnerships with raw material suppliers can help stabilize prices and ensure a consistent supply chain[1].

Conclusion

The market dynamics and financial trajectory for butyl alcohol in the pharmaceutical industry are characterized by robust growth driven by increasing demand from the pharmaceutical, automotive, and cosmetic sectors. The Asia Pacific region is expected to dominate the market, and the industry's shift towards sustainable practices further enhances the outlook for butyl alcohol.

Key Takeaways

  • Growing Demand: Increasing demand from the pharmaceutical and other industries drives the growth of the butyl alcohol market.
  • Regional Dominance: The Asia Pacific region is expected to dominate the global butyl alcohol market.
  • Sustainability: The push towards green chemistry and eco-friendly solvents boosts the demand for butyl alcohol.
  • Regulatory Compliance: The market faces regulatory challenges related to environmental and health safety.
  • Financial Projections: The global butyl alcohol market is projected to reach USD 20 billion by 2036.

FAQs

Q: What are the primary applications of butyl alcohol in the pharmaceutical industry?

A: Butyl alcohol is used as a solvent, intermediate, and excipient in the synthesis of active pharmaceutical ingredients (APIs) and other pharmaceutical products.

Q: Which region is expected to dominate the global butyl alcohol market?

A: The Asia Pacific region is expected to dominate the global butyl alcohol market due to robust industrial expansion in countries like China and India.

Q: What are the key drivers of the butyl alcohol market growth?

A: The key drivers include increasing demand from the pharmaceutical and cosmetic industries, regulatory and sustainability factors, and the expansion of the chemical industry.

Q: How does the volatility in raw material prices affect the butyl alcohol market?

A: The volatility in crude oil prices can impact the profitability of butyl alcohol manufacturers, but long-term supply contracts and advanced production technologies can mitigate these risks.

Q: What are the regulatory challenges faced by the butyl alcohol market?

A: The market faces regulatory challenges related to environmental and health safety, requiring compliance with stringent regulations to ensure minimal environmental and health risks.

Sources

  1. TechSci Research: Tertiary Butyl Alcohol Market By Size, Share and Forecast 2029F
  2. CIR Safety: Final Report of the Addendum to the Safety Assessment of n-Butyl Alcohol
  3. Research Nester: Butyl Alcohol Market Size & Share | Growth Forecasts 2036
  4. MarketsandMarkets: n-Butanol Market, Industry Size Growth Forecast Report, [Latest]
  5. PubMed: Final report of the addendum to the safety assessment of n-butyl alcohol

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.